改良负压辅助闭合(EndoVAC)治疗咽皮瘘:病例系列与文献综述
本文报告6例男性咽皮瘘患者接受改良由外向内EndoVAC技术的连续病例系列,并综述相关文献。单独EndoVAC治疗在5/6例(83.3%)中成功,中位治疗时长18.5天(范围7-32天),中位海绵更换4次(范围1-9次)。1例既往放化疗并空肠转移患者需额外重建手术,未观察到治疗相关并发症。
要点
- 改良EndoVAC技术操作简便、安全,可用于咽皮瘘治疗。
- 6例中5例(83.3%)单独EndoVAC治疗成功。
- 中位治疗18.5天,中位海绵更换4次,无治疗相关并发症。
核心结论
- EndoVAC治疗是治疗咽皮瘘的一种易于操作且安全的方法。
研究设计与样本
- 连续病例系列纳入6例男性咽皮瘘患者,均接受改良由外向内EndoVAC技术治疗,并附相关文献综述。
主要发现
- 单独EndoVAC治疗成功5/6例(83.3%)。
- EndoVAC治疗中位时长18.5天(范围7-32天)。
- EndoVAC海绵更换中位次数4次(范围1-9次)。
- 1例既往放化疗并空肠转移患者需额外重建手术。
- 未观察到治疗相关并发症。
临床怎么用
- 对于咽皮瘘患者,可考虑采用改良由外向内EndoVAC技术作为治疗选择。
局限性
- 证据来自小样本连续病例系列(6例),并非常规对照研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pharyngocutaneous fistula is a potential life-threatening complication following head and neck surgery. There is only limited evidence about the efficacy of vacuum-assisted closure (VAC) therapy and endoscopic vacuum-assisted closure (EndoVAC) therapy for the treatment of pharyngocutaneous fistulas. METHODS: In this article, we report on a consecutive case series of six male patients with pharyngocutaneous fistula treated with a modified outside-in EndoVAC technique. We also present a review of the current related literature. RESULTS: EndoVAC therapy alone was successful in five of the six patients (83.3%) with a median duration of EndoVAC therapy of 18.5 days (range: 7 to 32 days) and a median number of EndoVAC sponge changes of 4 (range: 1 to 9 changes). One patient needed additional reconstructive surgery after prior radiochemotherapy and jejunal transfer. No treatment-related complications were observed. CONCLUSION: EndoVAC therapy is an easy-to-perform, safe procedure for the treatment of pharyngocutaneous fistulae.
引用
- Steinbichler TB, Wolfram D, Runge A, et al. Modified vacuum-assisted closure (EndoVAC) therapy for treatment of pharyngocutaneous fistula: Case series and a review of the literature. Head Neck. 2021. PMID: 33830587. doi:10.1002/hed.26684
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。